Serum Institute Conducts Phase 3 Clinical Trial Of BCG Vaccine

The Serum Institute of India is conducting phase III clinical trial of BCG vaccine candidate VPM1002 to evaluate its ability in reducing infection and severe disease outcomes of COVID-19 among...